To mark World Aid’s Day (1 December 2022), medical writer Maddy Crabbe discusses the challenges faced by HIV patients, particularly the risks associated with respiratory infections like non-tuberculous myobacteria-associated pulmonary disease.
In May 2018, the World Health Organization (WHO) announced a global initiative to eliminate cervical cancer as a public health problem,1 where all countries must reach and maintain an incidence rate of below four per 100,000 women. Cervical cancer is the fourth most common female cancer worldwide and one of the top three cancers to affect women younger than 45,1 with an estimated 604,000 new cases and 342,000 deaths in 2020.2
Like everyone else, here at The Corpus we've had a strange 2021 – but have still fit a lot in! We take a look back at what we’ve achieved this past year and look forward to what 2022 might bring.
The use of AI to aid diagnosis has increasingly been heralded as an imminent evolution in the world of gastroenterology. As the FDA approves the first AI endoscopic device, what will it mean for physicians?
Could combining multiple biomarkers into one integrated score yield improved patient outcomes? With enhanced identification and stratification, this approach could generate more targeted treatment options.
Vaccine hesitancy has taken a strong hold of certain communities and has the potential to cause increasingly large, difficult-to-control outbreaks.